PUBLISHER: The Business Research Company | PRODUCT CODE: 1713475
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713475
Respiratory diagnostic devices and equipment are used to diagnose respiratory conditions like asthma, cystic fibrosis, and chronic obstructive pulmonary disease. These devices help measure lung function and oxygen levels, assisting healthcare providers in assessing and managing respiratory health.
The primary products within the respiratory devices and equipment (diagnostic) market encompass instruments and devices, as well as assays and reagents. These respiratory instruments and devices are critical for the diagnosis of various respiratory disorders. Diagnostic tests are available in various types, including traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests, all of which are employed in diagnosing conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, tuberculosis, and other respiratory diseases. These diagnostic tools are used in a variety of healthcare settings, including hospital and clinical laboratories, physician offices, reference laboratories, and other end-user facilities.
The respiratory devices and equipment (diagnostic) market research report is one of a series of new reports from The Business Research Company that provides respiratory devices and equipment (diagnostic) market statistics, including respiratory devices and equipment (diagnostic) industry global market size, regional shares, competitors with a respiratory devices and equipment (diagnostic) market share, detailed respiratory devices and equipment (diagnostic) market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory devices and equipment (diagnostic) industry. This respiratory devices and equipment (diagnostic) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The respiratory devices and equipment (diagnostic) market size has grown strongly in recent years. It will grow from $7.81 billion in 2024 to $8.41 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to chronic respiratory diseases, aging population, smoking and environmental factors, technological advancements.
The respiratory devices and equipment (diagnostic) market size is expected to see rapid growth in the next few years. It will grow to $12.37 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to respiratory infections, telemedicine and remote monitoring, personalized medicine, ai and machine learning. Major trends in the forecast period include pulmonary function testing (pft), home respiratory monitoring, telemedicine integration, smoking cessation aids.
The rising prevalence of various respiratory diseases has contributed to the growth of the global respiratory devices and equipment market by increasing the demand for diagnostic devices and equipment for diagnosis and treatment. Conditions such as chronic obstructive pulmonary disease (COPD) are particularly common among the elderly. COPD is an obstructive lung disease that causes long-term breathing difficulties. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, COPD was responsible for 7,691 deaths, or 29.6 per 100,000 people, accounting for 4.0% of all fatalities. As a result, the growing number of such cases has driven the demand for diagnostic devices and equipment, thus fueling the expansion of the respiratory devices and equipment (diagnostic) market.
The aging population is anticipated to be a key driver of growth in the respiratory devices and equipment market, especially in the diagnostic segment. An aging population refers to the demographic shift characterized by a rising proportion of elderly individuals within a society or population. Respiratory diagnostic devices and equipment play a pivotal role in monitoring and managing respiratory health for the aging population, aiding in early detection and intervention for conditions like COPD and sleep apnea. As of July 2022, the United Nations Department of Economic and Social Affairs has projected that the proportion of the world's population aged 65 and older is expected to increase from 10% in 2022 to 16% by 2050. Consequently, the growing aging population acts as a catalyst for the expansion of the respiratory devices and equipment (diagnostic) market.
Companies in the respiratory devices and equipment market are increasingly investing in portable and wireless diagnostic tools. This trend is driven by the ease of use, cost-effectiveness, advanced features, and their suitability for home care settings. Innovative, technology-enabled portable respiratory devices are being introduced to the market, offering immediate diagnosis of vital signs such as respiratory and pulse rates, in contrast to traditional devices. For example, in May 2024, the National Center for Biotechnology Information, a U.S.-based government agency, highlighted that this portable, noninvasive device provides immediate results, making it crucial for patients with chronic respiratory conditions like COPD and asthma. By offering on-site diagnostics, it improves patient outcomes and enhances the efficiency of healthcare systems.
Leading companies in the respiratory devices and equipment (diagnostic) market are focusing on developing advanced diagnostic technologies, such as automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, to improve the accuracy and speed of viral detection. These instruments and kits enable the quick and reliable extraction of viral genetic material for precise diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a U.S.-based biotechnology company, introduced Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, proteins, or cells, ensuring high-quality results for respiratory tests. It integrates with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, providing a comprehensive solution for in vitro diagnostics. With advanced data management and cybersecurity features, this system supports smooth workflows from sample preparation to real-time PCR analysis, making it suitable for both research and diagnostic purposes.
In January 2022, ICU Medical Inc., a U.S.-based medical device company, completed the acquisition of Smiths Medical for $2.35 billion. This strategic acquisition included Smiths Medical's syringe and ambulatory infusion devices, vascular access solutions, and vital care products. It was expected to strengthen ICU Medical's infusion therapy product portfolio and extend its offerings into emerging clinical care markets. Smiths Medical is a U.S.-based firm that develops, manufactures, and sells medical products, including diagnostic respiratory devices and equipment.
Major companies operating in the respiratory devices and equipment (diagnostic) market include ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Dragerwerk AG & Co. KGaA, Getinge AB, Drager Medical GmbH, bioMerieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC
Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2024. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the respiratory devices and equipment (diagnostic) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on respiratory devices and equipment (diagnostic) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for respiratory devices and equipment (diagnostic) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory devices and equipment (diagnostic) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.